Entity Common Stock, Shares Outstanding of ORAMED PHARMACEUTICALS INC. from 10 Jan 2012 to 12 Nov 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
ORAMED PHARMACEUTICALS INC. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 10 Jan 2012 to 12 Nov 2025.
  • ORAMED PHARMACEUTICALS INC. Entity Common Stock, Shares Outstanding for the quarter ending 12 Nov 2025 was 39,802,455, a 1.3% decline year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

ORAMED PHARMACEUTICALS INC. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 39,802,455 -509,614 -1.3% 12 Nov 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 41,003,600 +234,573 +0.58% 12 Aug 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 40,850,455 +331,295 +0.82% 27 Mar 2025 10-K/A 16 Jul 2025 2024 FY
Q3 2024 40,312,069 -26,910 -0.07% 07 Nov 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 40,769,027 +493,339 +1.2% 13 Aug 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 40,519,160 +735,347 +1.8% 06 Mar 2024 10-K 06 Mar 2024 2023 FY
Q3 2023 40,338,979 +1,224,243 +3.1% 09 Nov 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 40,275,688 +1,448,607 +3.7% 10 Aug 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 39,783,813 +1,219,797 +3.2% 06 Mar 2023 10-K 06 Mar 2023 2022 FY
Q3 2022 39,114,736 10 Nov 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 38,827,081 +6,312,936 +19% 10 Aug 2022 10-Q 10 Aug 2022 2022 Q2
Q1 2022 38,564,016 +8,335,595 +28% 30 Mar 2022 10-QT 30 Mar 2022 2021 Q2
Q4 2021 38,283,841 +11,622,837 +44% 11 Jan 2022 10-Q 11 Jan 2022 2022 Q1
Q2 2021 32,514,145 +8,987,333 +38% 14 Jul 2021 10-Q 14 Jul 2021 2021 Q3
Q1 2021 30,228,421 +7,134,443 +31% 13 Apr 2021 10-Q 13 Apr 2021 2021 Q2
Q4 2020 26,661,004 +8,925,229 +50% 14 Jan 2021 10-Q 14 Jan 2021 2021 Q1
Q2 2020 23,526,812 +6,143,453 +35% 07 Jul 2020 10-Q 07 Jul 2020 2020 Q3
Q1 2020 23,093,978 +5,713,119 +33% 05 Apr 2020 10-Q 06 Apr 2020 2020 Q2
Q4 2019 17,735,775 +357,416 +2.1% 09 Jan 2020 10-Q 09 Jan 2020 2020 Q1
Q2 2019 17,383,359 +20,744 +0.12% 09 Jul 2019 10-Q 10 Jul 2019 2019 Q3
Q1 2019 17,380,859 +2,938,176 +20% 09 Apr 2019 10-Q 10 Apr 2019 2019 Q2
Q4 2018 17,378,359 +3,007,429 +21% 11 Jan 2019 10-Q 14 Jan 2019 2019 Q1
Q2 2018 17,362,615 +4,041,653 +30% 11 Jul 2018 10-Q 12 Jul 2018 2018 Q3
Q1 2018 14,442,683 +1,148,191 +8.6% 06 Apr 2018 10-Q 09 Apr 2018 2018 Q2
Q4 2017 14,370,930 +1,087,578 +8.2% 10 Jan 2018 10-Q 11 Jan 2018 2018 Q1
Q2 2017 13,320,962 +184,304 +1.4% 04 Jul 2017 10-Q 06 Jul 2017 2017 Q3
Q1 2017 13,294,492 +178,501 +1.4% 04 Apr 2017 10-Q 05 Apr 2017 2017 Q2
Q4 2016 13,283,352 +187,691 +1.4% 10 Jan 2017 10-Q 11 Jan 2017 2017 Q1
Q2 2016 13,136,658 +1,585,812 +14% 05 Jul 2016 10-Q 06 Jul 2016 2016 Q3
Q1 2016 13,115,991 +2,292,048 +21% 05 Apr 2016 10-Q 06 Apr 2016 2016 Q2
Q4 2015 13,095,661 +2,262,530 +21% 12 Jan 2016 10-Q 13 Jan 2016 2016 Q1
Q2 2015 11,550,846 +1,594,855 +16% 30 Jun 2015 10-Q 01 Jul 2015 2015 Q3
Q1 2015 10,823,943 +881,354 +8.9% 31 Mar 2015 10-Q 03 Apr 2015 2015 Q2
Q4 2014 10,833,131 +1,087,965 +11% 06 Jan 2015 10-Q 08 Jan 2015 2015 Q1
Q3 2014 10,106,305 12 Nov 2014 10-K 14 Nov 2014 2014 FY
Q2 2014 9,955,991 +2,055,162 +26% 11 Jul 2014 10-Q 14 Jul 2014 2014 Q3
Q1 2014 9,942,589 +2,719,953 +38% 08 Apr 2014 10-Q 10 Apr 2014 2014 Q2
Q4 2013 9,745,166 -76,759,854 -89% 13 Jan 2014 10-Q 14 Jan 2014 2014 Q1
Q2 2013 7,900,829 -62,552,754 -89% 17 Jul 2013 10-Q 17 Jul 2013 2013 Q3
Q1 2013 7,222,636 -63,097,947 -90% 10 Apr 2013 10-Q 11 Apr 2013 2013 Q2
Q4 2012 86,505,020 +16,317,437 +23% 19 Dec 2012 10-Q 26 Dec 2012 2013 Q1
Q2 2012 70,453,583 11 Jul 2012 10-Q 12 Jul 2012 2012 Q3
Q1 2012 70,320,583 03 Apr 2012 10-Q 04 Apr 2012 2012 Q2
Q4 2011 70,187,583 10 Jan 2012 10-Q 12 Jan 2012 2012 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.